Company IM Cannabis Corp. Canadian Securities Exchange
Equities
IMCC
CA44969Q1090
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Cannabis
100.0
%
| 54 | 100.0 % | 49 | 100.0 % | -10.18% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
88.8
%
| 51 | 92.9 % | 43 | 88.8 % | -14.23% |
Germany
11.2
%
| 4 | 7.1 % | 5 | 11.2 % | +43.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oren Shuster
CEO | Chief Executive Officer | 55 | 10/10/19 |
Uri Birenberg
DFI | Director of Finance/CFO | 49 | 09/10/23 |
- | - | ||
Michal Nissimov
LAW | General Counsel | - | 30/05/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21/02/21 | |
Marc Lustig
CHM | Chairman | 51 | 10/10/19 |
Oren Shuster
CEO | Chief Executive Officer | 55 | 10/10/19 |
Einat Zakariya
BRD | Director/Board Member | - | 11/09/22 |
Moti Marcus
BRD | Director/Board Member | - | 12/09/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,394,136 | 8,593,293 ( 64.16 %) | 0 | 64.16 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+13.97% | 3.42B | |
+179.37% | 92.35M | |
+234.62% | 50.34M |